Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.

Saved in:
Bibliographic Details
Title: Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.
Authors: Lee, Cha Len1 (AUTHOR) chalen.lee@uhn.ca, Freeman, Mark2 (AUTHOR) vincent.tam@albertahealthservices.ca, Burak, Kelly W.3 (AUTHOR) kwburak@ucalgary.ca, Moffat, Gordon T.1 (AUTHOR), O'Donnell, Conor D. J.4 (AUTHOR), Ding, Philip Q.2 (AUTHOR), Lyubetska, Hanna5 (AUTHOR), Meyers, Brandon M.4 (AUTHOR), Gordon, Vallerie5 (AUTHOR), Kosyachkova, Ekaterina1 (AUTHOR), Bucur, Roxana1 (AUTHOR), Cheung, Winson Y.2 (AUTHOR), Knox, Jennifer J.1 (AUTHOR), Tam, Vincent C.2 (AUTHOR)
Source: Cancers. Aug2024, Vol. 16 Issue 16, p2878. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first